192 related articles for article (PubMed ID: 34656708)
1. Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review.
Wang Y; Zhang K; Yin L; Fu G; Liu Z
Ann Vasc Surg; 2022 Mar; 80():392.e1-392.e7. PubMed ID: 34656708
[TBL] [Abstract][Full Text] [Related]
2. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Hursting MJ; Levine RL; Leya F
Chest; 2006 Jun; 129(6):1407-16. PubMed ID: 16778256
[TBL] [Abstract][Full Text] [Related]
3. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
[TBL] [Abstract][Full Text] [Related]
4. Heparin-induced thrombocytopenia from venous thromboembolism treatment.
Begelman SM; Hursting MJ; Aghababian RV; McCollum D
J Intern Med; 2005 Dec; 258(6):563-72. PubMed ID: 16313480
[TBL] [Abstract][Full Text] [Related]
5. Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia.
Joseph L; Casanegra AI; Dhariwal M; Smith MA; Raju MG; Militello MA; Gomes MP; Gornik HL; Bartholomew JR
J Thromb Haemost; 2014 Jul; 12(7):1044-53. PubMed ID: 24766902
[TBL] [Abstract][Full Text] [Related]
6. Identifying patient- and treatment-related factors related to amputation risk in cases of heparin-induced thrombocytopenia treated with argatroban.
Haas S; Lewis B
Int Angiol; 2011 Dec; 30(6):541-6. PubMed ID: 22233615
[TBL] [Abstract][Full Text] [Related]
7. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
Warkentin TE
Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.
Murray PT; Hursting MJ
Ren Fail; 2006; 28(7):537-9. PubMed ID: 17050234
[TBL] [Abstract][Full Text] [Related]
9. Argatroban in the management of heparin-induced thrombocytopenia.
Babuin L; Pengo V
Vasc Health Risk Manag; 2010 Sep; 6():813-9. PubMed ID: 20859550
[TBL] [Abstract][Full Text] [Related]
10. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
Kondo LM; Wittkowsky AK; Wiggins BS
Ann Pharmacother; 2001 Apr; 35(4):440-51. PubMed ID: 11302409
[TBL] [Abstract][Full Text] [Related]
11. An overview of heparin-induced thrombocytopenia.
Donovan JL; Tran MT; Kanaan AO
J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818
[TBL] [Abstract][Full Text] [Related]
12. Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
Saugel B; Phillip V; Moessmer G; Schmid RM; Huber W
Crit Care; 2010; 14(3):R90. PubMed ID: 20487559
[TBL] [Abstract][Full Text] [Related]
13. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
[TBL] [Abstract][Full Text] [Related]
14. Treatment options for heparin-induced thrombocytopenia.
Greinacher A
Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
[TBL] [Abstract][Full Text] [Related]
15. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Berkowitz SD; Matthai WH; Fareed J; Walenga JM; Bartholomew J; Sham R; Lerner RG; Zeigler ZR; Rustagi PK; Jang IK; Rifkin SD; Moran J; Hursting MJ; Kelton JG;
Circulation; 2001 Apr; 103(14):1838-43. PubMed ID: 11294800
[TBL] [Abstract][Full Text] [Related]
16. A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT).
Makhija K; Chapman K; Prasad R
Pathology; 2021 Oct; 53(6):800-802. PubMed ID: 33610318
[No Abstract] [Full Text] [Related]
17. Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.
Yarbrough PM; Varedi A; Walker A; Rondina MT
Ann Pharmacother; 2012 Nov; 46(11):e30. PubMed ID: 23073302
[TBL] [Abstract][Full Text] [Related]
18. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
[TBL] [Abstract][Full Text] [Related]
19. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.
Mohanty E; Nazir S; Sheppard JI; Forman DA; Warkentin TE
J Thromb Haemost; 2019 May; 17(5):841-844. PubMed ID: 30773806
[TBL] [Abstract][Full Text] [Related]
20. Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia.
Davis KA; Davis DO
Eur J Haematol; 2017 Oct; 99(4):332-335. PubMed ID: 28672052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
